Category Archives: Uncategorized

25 Oct

Call restricted to Member States for projects aimed at furthering the Commission Recommendation on proportionate police checks and police cooperation in the Schengen area

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: ISFP-2018-AG-SCHENPillar: Police cooperationOpening Date: Deadline: Thu, 2 May 2019 17:00:00 (Brussels local time)Modification Date: Thu, 25 Oct

24 Oct

Medisafe to Get Paid For Health App’s Performance

More technology startups are embracing the healthcare industry’s increasing willingness to pay for products based on how much they improve

24 Oct

FAST TRACK TO INNOVATION (FTI)

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-EIC-FTI-2018-2020Pillar: Industrial LeadershipOpening Date: Deadline: Tue, 23 Oct 2018 17:00:00 (Brussels local time)Modification Date: Wed, 24 Oct

24 Oct

2018 Blue Economy call 1217

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: EMFF-BlueEconomy-2018Pillar: EMFF-1-1Opening Date: Deadline: Thu, 31 Jan 2019 17:00:00 (Brussels local time)Modification Date: Tue, 23 Oct 2018Latest

23 Oct

NeoGenomics Buys Ex-Novartis Cancer Lab Genoptix for $125M, Stock

Cancer testing laboratory Genoptix is being acquired by NeoGenomics, another cancer-focused genetic testing business, for $125 million in cash and

23 Oct

Horizon 2020 Brokerage Event on Nanotechnology, Advanced Materials, Manufacturing & Processing  – 20 November 2018, Birmingham, UK

[Source: Research & Innovation] The Enterprise Europe Network in partnership with the Science and Innovation Network, BEIS, Innovate UK and

23 Oct

Patient Advocates Sounding the Alarm Over Fail First

The Centers for Medicare & Medicaid Services (CMS) has reversed a long-standing policy allowing Medicare Advantage plans to impose “step

22 Oct

Centrexion Plans IPO to Bankroll Non-Opioid Pain Drugs

Centrexion Therapeutics is notable for focusing solely on developing non-opioid, non-addictive pain drugs-an area that biopharma companies have largely avoided.

22 Oct

Making SMA Newborn Screening a Reality: Collaborating with the Patient Advocacy Community

Each year, roughly 12,500 newborns in the U.S., or one out of every 300 infants, are diagnosed with one of

22 Oct

For a better innovation support to SMEs

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-INNOSUP-2018-2020Pillar: Industrial LeadershipOpening Date: Deadline: Thu, 12 Apr 2018 17:00:00 (Brussels local time)Modification Date: Mon, 22 Oct